ロード中...
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
INTRODUCTION: Psoriatic arthritis (PsA) is a spondyloarthritis that occurs in up to 30% of psoriasis patients. Patients with PsA are at risk for decreased quality of life due to both joint and skin symptoms, impaired physical function and disease progression. Treatments include non-steroidal anti-in...
保存先:
| 出版年: | Rheumatol Ther |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883260/ https://ncbi.nlm.nih.gov/pubmed/27747762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-014-0005-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|